Anti-tissue transglutaminase antibody inhibits apoptotic cell clearance by macrophages in pregnant NOD mice

Journal of Reproductive Immunology

Volumn 103, Issue 1, 2014, Pages 59-66

  Sóñora, Cecilia ^a,b   Mourglia Ettlin, Gustavo ^a   Calo, Guillermina ^c   Hauk, Vanesa ^c   Ramhorst, Rosanna ^c   Hernández, Ana ^a   Leirós, Claudia Pérez ^c  

^a UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^b DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Anti tissue transglutaminase antibodies; Celiac disease; NOD mice

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; ANTIBODY; AUTOANTIGEN; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELIAC DISEASE; CELL PHAGOCYTOSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; FIRST TRIMESTER PREGNANCY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PERITONEUM MACROPHAGE; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; PHAGOCYTOSIS; PREGNANCY OUTCOME; SJOEGREN SYNDROME; UTERUS;

ANIMALS; ANTIBODIES; APOPTOSIS; AUTOANTIGENS; CELIAC DISEASE; DIABETES MELLITUS, TYPE 1; FEMALE; GTP-BINDING PROTEINS; IMMUNOGLOBULIN G; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; PHAGOCYTOSIS; PREGNANCY; PREGNANCY OUTCOME; SJOGREN'S SYNDROME; TRANSGLUTAMINASES; UTERUS;

EID: 84900305237     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2013.11.001     Document Type: Article

References (43)

1. Abrahams V.M., Kim Y.M., Straszewski S.L., Romero R., Mor G. Macrophages and apoptotic cell clearance during pregnancy. Am. J. Reprod. Immunol. 2004, 51:275-282.
2. Akimov S.S., Belkin A.M. Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood 2001, 98:1567-1576.
3. Bardella M.T., Fredella C., Saladino V., Trovato C., Cesana B.M., Quatrini M., et al. Gluten intolerance: gender- and age-related differences in symptoms. Scand. J. Gastroenterol. 2005, 40:15-19.
4. Belkin A.M. Extracellular TG2: emerging functions and regulation. FEBS J. 2011, 278:4704-4716.
5. Burke S.D., Dong H., Hazan A.D., Croy B.A. Aberrant endometrial features of pregnancy in diabetic NOD mice. Diabetes 2007, 56:2919-2926.
6. Caja S., Maki M., Kaukinen K., Lindfors K. Antibodies in celiac disease: implications beyond diagnostics. Cell. Mol. Immunol. 2011, 8:103-109.
7. Cataldo F., Montalto G. Celiac disease in the developing countries: a new and challenging public health problem. World J. Gastroenterol. 2007, 13:2153-2159.
8. Ciacci C., Cirillo M., Auriemma G., Di Dato G., Sabbatini F., Mazzacca G. Celiac disease and pregnancy outcome. Am. J. Gastroenterol. 1996, 91:718-722.
9. Delaleu N., Nguyen C.Q., Peck A.B., Jonsson R. Sjogren's syndrome: studying the disease in mice. Arthritis Res. Ther. 2011, 13:217.
10. Di Niro R., Ferrara F., Not T., Bradbury A.R., Chirdo F., Marzari R., et al. Characterizing monoclonal antibody epitopes by filtered gene fragment phage display. Biochem. J. 2005, 388:889-894.
11. Di Sabatino A., Vanoli A., Giuffrida P., Luinetti O., Solcia E., Corazza G.R. The function of tissue transglutaminase in celiac disease. Autoimmun. Rev. 2012, 11:746-753.
12. Dieterich W., Ehnis T., Bauer M., Donner P., Volta U., Riecken E.O., et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat. Med. 1997, 3:797-801.
13. Dube C., Rostom A., Sy R., Cranney A., Saloojee N., Garritty C., et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology 2005, 128:S57-S67.
14. Fasano A., Berti I., Gerarduzzi T., Not T., Colletti R.B., Drago S., et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch. Intern. Med. 2003, 163:286-292.
15. Fest S., Aldo P.B., Abrahams V.M., Visintin I., Alvero A., Chen R., et al. Trophoblast-macrophage interactions: a regulatory network for the protection of pregnancy. Am. J. Reprod. Immunol. 2007, 57:55-66.
16. Fesus L., Piacentini M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem. Sci. 2002, 27:534-539.
17. Garrote J.A., Gomez-Gonzalez E., Bernardo D., Arranz E., Chirdo F. Celiac disease pathogenesis: the proinflammatory cytokine network. J. Pediatr. Gastroenterol. Nutr. 2008, 47(Suppl. 1):S27-S32.
18. Kabir-Salmani M., Shiokawa S., Akimoto Y., Sakai K., Iwashita M. Tissue transglutaminase at embryo-maternal interface. J. Clin. Endocrinol. Metab. 2005, 90:4694-4702.
19. Larocca L., Hauk V., Calafat M., Roca V., Fraccaroli L., Franchi A., et al. Modulation of macrophage inflammatory profile in pregnant nonobese diabetic (NOD) mice. Mol. Cell. Endocrinol. 2011, 333:112-118.
20. Lin Y., Xu L., Jin H., Zhong Y., Di J., Lin Q.D. CXCL12 enhances exogenous CD4+CD25+T cell migration and prevents embryo loss in non-obese diabetic mice. Fertil. Steril. 2009, 91:2687-2696.
21. Lindfors K., Maki M., Kaukinen K. Transglutaminase 2-targeted autoantibodies in celiac disease: pathogenetic players in addition to diagnostic tools?. Autoimmun. Rev. 2010, 9:744-749.
22. Martinelli P., Troncone R., Paparo F., Torre P., Trapanese E., Fasano C., et al. Coeliac disease and unfavourable outcome of pregnancy. Gut 2000, 46:332-335.
23. Mehta K., Lopez-Berestein G., Moore W.T., Davies P.J. Interferon-gamma requires serum retinoids to promote the expression of tissue transglutaminase in cultured human blood monocytes. J. Immunol. 1985, 134:2053-2056.
24. Mor G., Cardenas I. The immune system in pregnancy: a unique complexity. Am. J. Reprod. Immunol. 2010, 63:425-433.
25. Murtaugh M.P., Mehta K., Johnson J., Myers M., Juliano R.L., Davies P.J. Induction of tissue transglutaminase in mouse peritoneal macrophages. J. Biol. Chem. 1983, 258:11074-11081.
26. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
27. Nagamatsu T., Schust D.J. The contribution of macrophages to normal and pathological pregnancies. Am. J. Reprod. Immunol. 2010, 63:460-471.
28. Ozgor B., Selimoglu M.A. Coeliac disease and reproductive disorders. Scand. J. Gastroenterol. 2010, 45:395-402.
29. Robinson N.J., Glazier J.D., Greenwood S.L., Baker P.N., Aplin J.D. Tissue transglutaminase expression and activity in placenta. Placenta 2006, 27:148-157.
30. Roca V., Calafat M., Larocca L., Ramhorst R., Farina M., Franchi A.M., et al. Potential immunomodulatory role of VIP in the implantation sites of prediabetic nonobese diabetic mice. Reproduction 2009, 138:733-742.
31. Rossin F., D'Eletto M., Macdonald D., Farrace M.G., Piacentini M. TG2 transamidating activity acts as a reostat controlling the interplay between apoptosis and autophagy. Amino Acids 2012, 42:1793-1802.
32. Sblattero D., Maurano F., Mazzarella G., Rossi M., Auricchio S., Florian F., et al. Characterization of the anti-tissue transglutaminase antibody response in nonobese diabetic mice. J. Immunol. 2005, 174:5830-5836.
33. Signorini M., Pansini F., Bonaccorsi G., Mollica G., Ferrari C., Bergamini C.M. Regulation of endometrial transglutaminase activity during the menstrual cycle. Biochem. Int. 1988, 16:77-82.
34. Soni S., Badawy S.Z. Celiac disease and its effect on human reproduction: a review. J. Reprod. Med. 2010, 55:3-8.
35. Sonora C., Munoz F., Del Rio N., Acosta G., Montenegro C., Trucco E., et al. Celiac disease and gyneco-obstetrics complications: can serum antibodies modulate tissue transglutaminase functions and contribute to clinical pattern?. Am. J. Reprod. Immunol. 2011, 66:476-487.
36. Straszewski-Chavez S.L., Abrahams V.M., Mor G. The role of apoptosis in the regulation of trophoblast survival and differentiation during pregnancy. Endocr. Rev. 2005, 26:877-897.
37. -/- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:7812-7817.
38. Thomas J.W., Kendall P.L., Mitchell H.G. The natural autoantibody repertoire of nonobese diabetic mice is highly active. J. Immunol. 2002, 169:6617-6624.
39. Toth B., Garabuczi E., Sarang Z., Vereb G., Vamosi G., Aeschlimann D., et al. Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells. J. Immunol. 2009, 182:2084-2092.
40. Upchurch H.F., Conway E., Patterson M.K., Maxwell M.D. Localization of cellular transglutaminase on the extracellular matrix after wounding: characteristics of the matrix bound enzyme. J. Cell. Physiol. 1991, 149:375-382.
41. Verderio E., Gaudry C., Gross S., Smith C., Downes S., Griffin M. Regulation of cell surface tissue transglutaminase: effects on matrix storage of latent transforming growth factor-beta binding protein-1. J. Histochem. Cytochem. 1999, 47:1417-1432.
42. Wicker L.S., Clark J., Fraser H.I., Garner V.E., Gonzalez-Munoz A., Healy B., et al. Type 1 diabetes genes and pathways shared by humans and NOD mice. J. Autoimmun. 2005, 25:29-33. Suppl.
43. Yu L., Robles D.T., Abiru N., Kaur P., Rewers M., Kelemen K., et al. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:1701-1706.